This international course offers 3,5 days of lectures and discussions centered on the biology of immunity and cancer immunotherapy. Conferences are delivered by experts who will present the latest developments in the different fields of immunology, including innate immunity, myeloid and lymphoid cell biology, and the microenvironment’s role in the activation of immunity. A thematic session will cover the state-of-the-art in cell therapy for cancer. A round table on industrial opportunities associated to immunotherapies and career development in the field of immuno-oncology will be organized. Participants will have the opportunity to present their research during two poster sessions and may be selected for a short oral presentation. In addition to highlighting the latest basic and applied research results in immunology, this workshop aims at fostering discussions and collaborations between participants (on a non-confidential basis).
The cell therapy session is organized and funded by the RHU EpCART and the PSCC-Curie Biocluster, which are two structuring projects funded by the ANR (French National Research Agency) and France 2030.
The course is organized and funded by the LabEx DCBIOL, CIML and Institut Curie’s Advanced Training Office.
The course organised by the LabEx DCBIOL aims to provide to the participants, free of charge, 3,5 days of state-of-the-art lectures in immunology, including cancer immunotherapy. The course will include elements of basic, translational, and medical research. Speakers have been selected based on their excellence in research and ability to communicate their results to an audience. By regrouping for 3,5 days speakers and participants, we expect to greatly foster discussions, that could lead to collaborations. This will be favored by the organization of poster and short talk sessions delivered by the participants. A round table on industrial opportunities associated to immunotherapies will further allow to reflect on career choices in the field. Overall, this course will participate in building a network in the field of immunology and immunotherapy (researchers, care givers and industrial partners).
Participants will be selected for poster and short talk presentation.
Round table on industrial opportunities and careers associated to immunotherapies.
CV and motivation letter required. Poster abstract encouraged.
Marion ALCANTARA - FR
Grégoire ALTAN-BONNET - US
Sebastian AMIGORENA - FR
Philippe BENAROCH - FR
Justin EYQUEM - US
Mauro GAYA - FR
Elisa GOMEZ PERDIGUERO - FR
Sandrine HENRI - FR
Claire HIVROZ - FR
Olivier LANTZ - FR
Christopher KLEBANOFF - US
Ana-Maria LENNON-DUMENIL - FR
Parinaz MEHDIPOUR - UK
Mickael MENAGER - FR
Maria MITTELBRUNN - ES
Eliane PIAGGIO - FR
Enzo POIRIER - FR
Jan REHWINKEL - UK
Caetano REIS E SOUSA - UK
Rejane RUA - FR
Elena TOMASELLO - FR
Eric VIVIER - FR
Aleksandra WALCZAK - FR
Josh WATERFALL - FR
Florent GINHOUX - FR
This list of speakers may still change
Josh Waterfall, U830, Institut Curie, Paris
Enzo Poirier, U932, Institut Curie, Paris
Ana-Maria Lennon-Duménil, U932, Institut Curie, Paris
Nathalie Amzallag, U932, Institut Curie, Paris
Philippe Pierre, CIML, Marseille
Evelina Gatti, CIML, Marseille
Sophie De Bentzmann, CIML, Marseille
Giovanna Chimini, CIML, Marseille
Josh Waterfall, U830, Institut Curie, Paris
Enzo Poirier, U932, Institut Curie, Paris
Ana-Maria Lennon-Duménil, U932, Institut Curie, Paris
Nathalie Amzallag, U932, Institut Curie, Paris
Philippe Pierre, CIML, Marseille
Evelina Gatti, CIML, Marseille
Sophie De Bentzmann, CIML, Marseille
Giovanna Chimini, CIML, Marseille
Registration is open to anyone holding a Bachelor's degree or equivalent. All courses will be held in English.
Basic knowledge in immunology will help you get the most from this course.
Free registration.
Hotel, transportation, and dinner on June 21st not included.
150 participants
The course’s organizing committee will select candidates based on their CV, motivation letter, research topic and willingness to participate to the poster sessions/short talks. Total of 150 participants.
Targeted audience: All scientists holding a Bachelor’s degree (in priority in immunology).
